Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 15,000 shares at $46.75 ($701K) on 2015-05-29, disclosed to the SEC on 2015-06-01.
Scheduled sale ($701k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.75 | 11,000 | $514K | 73.3% |
| 2 | $46.79 | 4,000 | $187K | 26.7% |
| Total | $46.76 avg | 15,000 | $701K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |